# Prospective Validation Study of the CD8+TEMRA Cells As a Prognostic Biomarker of Healing Outcome After Fracture

> **NCT06658379** · — · RECRUITING · sponsor: **Charite University, Berlin, Germany** · enrollment: 640 (estimated)

## Conditions studied

- Fracture Non Union
- Fracture Healing
- Long Bone Delayed-Union Fracture
- Humerus Shaft Fracture
- Forearm Fracture
- Femoral Neck Fractures
- Femur Distal Fracture
- Pertrochanteric Fracture of Femur
- Femoral Shaft Fracture
- Proximal Tibia Fracture
- Tibial Shaft Fracture
- Distal Tibia Fracture

## Interventions

- **DIAGNOSTIC_TEST:** CD8+TEMRA

## Key facts

- **NCT ID:** NCT06658379
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2016-12
- **Primary completion:** 2025-04
- **Final completion:** 2025-06
- **Target enrollment:** 640 (ESTIMATED)
- **Last updated:** 2024-10-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06658379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06658379, "Prospective Validation Study of the CD8+TEMRA Cells As a Prognostic Biomarker of Healing Outcome After Fracture". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06658379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*